CDH22 is downregulated by methylation and acts as an independent prognostic factor in breast cancer by Mendaza, S, Martín-Sánchez, E, Ulazia-Garmendia, A, Monreal-Santesteban, I, Córdoba, A, Vicente-García, F, De la Cruz, S, Blanco-Luquin, I, Guerrero-Setas, D

Get full text

CHL1 methylation may act as a tumour suppressor gene and predicts poor prognosis in breast cancer by Martín-Sánchez, E, Mendaza, S, Ulazia-Garmendia, A, Monreal-Santesteban, I, Córdoba, A, Vicente-García, F, Illarramendi, J.J, Blanco-Luquin, I, Pernaut-Leza, E, Guerrero-Setas, D

Get full text

Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 1... by Martín-Sánchez, E., Pernaut-Leza, E., Mendaza, S., Cordoba, A., Vicente-Garcia, F., Monreal-Santesteban, I., Vizcaino, J. Pérez, De Cerio, M. J. Díaz, Perez-Janices, N., Blanco-Luquin, I., Escors, D., Ulazia-Garmendia, A., Guerrero-Setas, D.

Get full text

PO-388 Epigenetic silencing of ZNF177 by MIR-877–3 p could be involved in cervical cancer progression by Martín-Sánchez, E, Guarch, R, Blanco-Luquin, I, Mendaza, S, Ulazia-Garmendia, A, Monreal-Santesteban, I, Vidal, A, Salas, J Santos, Guiu, XM, Guerrero-Setas, D

Get full text

820 - CDH22 is downregulated by methylation and acts as an independent prognostic factor in breast cancer by Mendaza, S., Martín-Sánchez, E., Ulazia-Garmendia, A., Monreal-Santesteban, I., Córdoba, A., Vicente-García, F., De la Cruz, S., Blanco-Luquin, I., Guerrero-Setas, D.

Get full text

815 - CHL1 methylation may act as a tumour suppressor gene and predicts poor prognosis in breast cancer by Martín-Sánchez, E., Mendaza, S., Ulazia-Garmendia, A., Monreal-Santesteban, I., Córdoba, A., Vicente-García, F., Illarramendi, J.J., Blanco-Luquin, I., Pernaut-Leza, E., Guerrero-Setas, D.

Get full text

PO-387 Differential gene methylation in triple negative breast cancer and non-tumoral mammary tissue by Garmendia, A. Ulazia, Martín-Sánchez, E., Mendaza, S., Monreal-Santesteban, I., Córdoba, A., Ruiz de Azúa, Y., Coca, V., Guerrero-Setas, D.

Get full text

ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer by Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Córdoba, Alicia, Azúa, Yerani Ruiz de, Aguiar, Begoña, Beloqui, Raquel, Armendáriz, Pedro, Arriola, Marta, Martín-Sánchez, Esperanza, Guerrero-Setas, David

Get full text

A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis by Mendaza, Saioa, Guerrero-Setas, David, Monreal-Santesteban, Iñaki, Ulazia-Garmendia, Ane, Cordoba Iturriagagoitia, Alicia, De la Cruz, Susana, Martín-Sánchez, Esperanza

Get full text

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer by Martín-Sánchez, Esperanza, Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Blanco-Luquin, Idoia, Córdoba, Alicia, Vicente-García, Francisco, Pérez-Janices, Noemí, Escors, David, Megías, Diego, López-Serra, Paula, Esteller, Manel, Illarramendi, José Juan, Guerrero-Setas, David

Get full text

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer by Martín-Sánchez, Esperanza, Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Córdoba, Alicia, Vicente-García, Francisco, Blanco-Luquin, Idoia, De La Cruz, Susana, Aramendia, Ana, Guerrero-Setas, David

Get full text